<DOC>
	<DOC>NCT01316679</DOC>
	<brief_summary>Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.</brief_summary>
	<brief_title>An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Ability and willingness to provide written informed consent Must be between 1890 years of age at the time of consent Ability to provide urine specimen at protocoldefined timepoints Must have treatment interventions planned that are directly related to liver disease (excluding those assigned to group 3Controls) Suspected inability, e.g. unwillingness to comply with study procedures or unwillingness to provide written consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>HCC</keyword>
	<keyword>Liver Disease without HCC</keyword>
</DOC>